<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="138445">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01298778</url>
  </required_header>
  <id_info>
    <org_study_id>IRB 00012376</org_study_id>
    <nct_id>NCT01298778</nct_id>
  </id_info>
  <brief_title>High Pain Intervention in Cesarean Sections</brief_title>
  <official_title>Improving Pain Relief For Those Who Need It Most After Cesarean Delivery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wake Forest University Health Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wake Forest University Health Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In previous studies the investigators have seen that the severity of pain one day after
      cesarean delivery can predict the presence of pain and depression 2 months later. The
      investigators believe those at risk for severe acute post-partum pain can be identified, and
      medical interventions can be tailored to manage postoperative pain more effectively.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is randomizing patients into 2 different groups and seeing if by altering our
      pain management with this group of patients their acute 24 hour evoked pain is less than
      anticipated; and the incidence of persistent pain and depression when contacted 2 months
      after delivery is decreased. This study is designed to see if these additional interventions
      would prove effective for patients at risk of having high pain level after cesarean surgery.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2010</start_date>
  <completion_date type="Actual">July 2011</completion_date>
  <primary_completion_date type="Actual">July 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Severity of acute pain</measure>
    <time_frame>24 hour</time_frame>
    <description>to determine whether an intervention in women predicted to experience severe pain after cesarean delivery reduces acute post-delivery pain (24 hour evoked pain post delivery)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of depression and Persistent Pain</measure>
    <time_frame>2 months</time_frame>
    <description>to determine whether an intervention in women predicted to experience severe pain after cesarean delivery reduces postpartum depression and persistent pain up to 2 months post delivery. &lt;These are the 2 Main Secondary outcome measures&gt;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain</measure>
    <time_frame>24 hour</time_frame>
    <description>resting pain, average pain, worst pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>analgesic consumption</measure>
    <time_frame>24 hour</time_frame>
    <description>total amount of analgesic consumption</description>
  </secondary_outcome>
  <other_outcome>
    <measure>pruritus</measure>
    <time_frame>24 hours</time_frame>
    <description>side effects</description>
  </other_outcome>
  <other_outcome>
    <measure>emetic symptoms</measure>
    <time_frame>24hours</time_frame>
    <description>side effects</description>
  </other_outcome>
  <other_outcome>
    <measure>respiratory depression</measure>
    <time_frame>24hr</time_frame>
    <description>side effect</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Other Chronic Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Standard of care</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Spinal consists of duramorph 150 mcg combined with fentanyl and bupivacaine in conjunction with placebo capsules 2 PO q 6 hrs x 4 doses in first 24 hrs postop. Ibuprofen given as standard of care.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Acetaminophen and increased dose of Duramorph</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Spinal consists of duramorph 300 mcg combined with fentanyl and bupivacaine in conjunction with Acetaminophen 1 Gm PO q 6 hrs x 4 doses in first 24 hrs postop. Ibuprofen given as standard of care.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Duramorph</intervention_name>
    <description>Duramorph 150 mcg x 1 dose spinally + placebo capsules 2 PO q 6 hrs first 24 hrs postop x 4 doses</description>
    <arm_group_label>Standard of care</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acetaminophen</intervention_name>
    <description>Duramorph 300 mcg spinally + acetaminophen 1 GM q 6 hrs first 24 hrs postop x 4 doses</description>
    <arm_group_label>Acetaminophen and increased dose of Duramorph</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  elective cesarean section

          -  age &gt;/= 18 years old

          -  not allergic proposed study medications

          -  predicted to experience high pain postop based on preoperative evaluation

        Exclusion Criteria:

          -  allergy to study medications

          -  known hepatic disease

          -  weight &gt; 300 lbs
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter H. Pan, MD, MSEE</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wake Forest University Health Sciences</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Forsyth Medical Center-Sara Lee Center for Women's Health</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 5, 2013</lastchanged_date>
  <firstreceived_date>February 17, 2011</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Wake Forest School of Medicine</investigator_affiliation>
    <investigator_full_name>Dr. Peter H. Pan, M.D., MSEE</investigator_full_name>
    <investigator_title>Anesthesiologist</investigator_title>
  </responsible_party>
  <keyword>chronic pain post delivery</keyword>
  <keyword>postpartum depression</keyword>
  <keyword>tailored pain management</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Acetaminophen</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
